Senate debates Committees

Community Affairs References Committee; Reference


Mathias Cormann

Mathias Cormann WA, Liberal Party, Shadow Parliamentary Secretary for Health Administration

3:44 pm

I move:

That the following matter be referred to the Community Affairs References Committee for inquiry and report by 30 June 2010:Consumer access to pharmaceutical benefits and the creation of new therapeutic groups through the Pharmaceutical Benefits Scheme (PBS), including:

(a)
the impact of new therapeutic groups on consumer access to existing PBS drugs, vaccines and future drugs, particularly high cost drugs;
(b)
the criteria and clinical evidence used to qualify drugs as interchangeable at a patient level;
(c)
the effect of new therapeutic groups on the number and size of patient contributions;
(d)
consultation undertaken in the development of new therapeutic groups;
(e)
the impact of new therapeutic groups on the classification of medicines in F1 and F2 formularies;
(f)
the delay to price reductions associated with the price disclosure provisions due to take effect on 1 August 2009 and the reasons for the delay;
(g)
the process and timing of consideration by Cabinet of high cost drugs and vaccines; and
(h)
any other related matters.

Question agreed to.

Kerry O'Brien

Kerry O'Brien Tasmania, Australian Labor Party

by leave—The government opposes this motion. We recognise that the opposition has the support of the Greens for this motion and therefore it has a majority. We will not be calling for a division.